Related references
Note: Only part of the references are listed.
Article
Virology
Lori A. Rowe et al.
Summary: In recent months, new variants of SARS-CoV-2 that are more transmissible and can escape host immunity have emerged. Little is known about the evolution of SARS-CoV-2 in nonhuman primate models. This study sequenced viral RNA from rectal swabs of African green monkeys infected with SARS-CoV-2. Two distinct patterns of viral evolution were identified, and the importance of the furin cleavage site for in vivo infection was confirmed.
Article
Pathology
Rhonda K. Yantiss et al.
Summary: Approximately 20% of patients with symptomatic SARS-CoV-2 infection experience gastrointestinal bleeding and/or diarrhea. Most cases do not require endoscopic evaluation due to the risk of practitioner infection outweighing the value of biopsy analysis. Current knowledge about gastrointestinal manifestations of COVID-19 comes primarily from surgical and autopsy cases, with no detailed reports describing other gastrointestinal effects.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY
(2022)
Article
Medicine, General & Internal
D. M. Weinreich et al.
Summary: Recent data indicate that complications and death from Covid-19 may be related to high viral loads. In this trial involving nonhospitalized patients, a cocktail of two neutralizing monoclonal antibodies (REGN-COV2) reduced viral load, with a greater effect in patients with no immune response or high viral load at baseline. Safety outcomes were similar between REGN-COV2 dose groups and the placebo group.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Microbiology
Allison J. Greaney et al.
Summary: The evolution of SARS-CoV-2 may impact the recognition of the virus by human antibody-mediated immunity, with mutations affecting antibody binding varying significantly among individuals and within the same individual over time. Despite this variability, mutations that greatly reduce antibody binding usually occur at specific sites in the RBD, with E484 being the most crucial. These findings can inform surveillance efforts for SARS-CoV-2 evolution in the future.
CELL HOST & MICROBE
(2021)
Article
Multidisciplinary Sciences
Carolina Lucas et al.
Summary: This study found that individuals previously infected with the virus had higher antibody titres post-vaccination compared to those who were uninfected, but both groups reached comparable levels of neutralization responses to the ancestral strain after the second vaccine dose. Comprehensive analysis of 16 locally circulating SARS-CoV-2 variants revealed varying degrees of reduction in neutralization capacity associated with specific mutations in the spike gene, suggesting vaccine boosters as a relevant future strategy to counteract the impact of emerging variants on antibody neutralizing activity.
Article
Immunology
Brandon J. Beddingfield et al.
Summary: The study in rhesus macaques showed that combinatory parenteral administration of two high-affinity anti-SARS-CoV-2 monoclonal antibodies effectively blocked the development of COVID-19 and accelerated the prospect of clinical studies with this antibody combination. The dose and timing of administration had an impact on the efficacy of infection prevention.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
(2021)
Review
Microbiology
William T. Harvey et al.
Summary: The evolution of SARS-CoV-2 has been characterized by the emergence of mutations and variants that impact virus characteristics. Manufacturers are preparing for possible updates to vaccines in response to changes in the virus population, and it is crucial to monitor genetic and antigenic changes alongside experiments to understand the impacts of mutations.
NATURE REVIEWS MICROBIOLOGY
(2021)
Article
Microbiology
Michihito Sasaki et al.
Summary: Studies have shown that the loss of the furin cleavage site results in attenuation of SARS-CoV-2 variants in airway tissues of hamsters, with minimal impact on weight loss and inflammatory response. These mutants induce sufficient levels of neutralizing antibodies in hamsters, providing protective immunity against both parental strains and emerging SARS-CoV-2 variants.
Article
Microbiology
Koen K. A. Van Rompay et al.
Summary: The combination of the potent monoclonal antibodies C135-LS and C144-LS improved clinical symptoms, reduced virus replication in the respiratory tract, and significantly decreased lung inflammation in macaques infected with SARS-CoV-2. These findings suggest potential therapeutic benefits of these antibodies in early COVID-19 infection.
Article
Multidisciplinary Sciences
Petra Mlcochova et al.
Summary: The B.1.617.2 (Delta) variant of SARS-CoV-2 has lower sensitivity to antibodies and higher replication efficiency compared to other lineages, which may contribute to its dominance and reduced vaccine effectiveness, highlighting the need for continued infection control measures post-vaccination.
Editorial Material
Gastroenterology & Hepatology
Fei Xiao et al.
Article
Gastroenterology & Hepatology
Lei Pan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY
(2020)
Review
Gastroenterology & Hepatology
Chunxiang Ma et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY
(2020)
Article
Multidisciplinary Sciences
Davide F. Robbiani et al.
Article
Immunology
Siu-Ying Lau et al.
EMERGING MICROBES & INFECTIONS
(2020)
